189 related articles for article (PubMed ID: 27871038)
1. Imidazopyridine-fused [1,3]-diazepinones part 2: Structure-activity relationships and antiproliferative activity against melanoma cells.
Bellet V; Lichon L; Arama DP; Gallud A; Lisowski V; Maillard LT; Garcia M; Martinez J; Masurier N
Eur J Med Chem; 2017 Jan; 125():1225-1234. PubMed ID: 27871038
[TBL] [Abstract][Full Text] [Related]
2. Imidazopyridine-fused [1,3]-diazepinones: synthesis and antiproliferative activity.
Gallud A; Vaillant O; Maillard LT; Arama DP; Dubois J; Maynadier M; Lisowski V; Garcia M; Martinez J; Masurier N
Eur J Med Chem; 2014 Mar; 75():382-90. PubMed ID: 24561668
[TBL] [Abstract][Full Text] [Related]
3. Imidazopyridine-fused [1,3]diazepinones: modulations of positions 2 to 4 and their impacts on the anti-melanoma activity.
Baccon-Sollier PL; Malki Y; Maye M; Ali LMA; Lichon L; Cuq P; Vincent LA; Masurier N
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):935-949. PubMed ID: 32249633
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Garamvölgyi R; Dobos J; Sipos A; Boros S; Illyés E; Baska F; Kékesi L; Szabadkai I; Szántai-Kis C; Kéri G; Őrfi L
Eur J Med Chem; 2016 Jan; 108():623-643. PubMed ID: 26724730
[TBL] [Abstract][Full Text] [Related]
5. Pyrido-imidazodiazepinones as a new class of reversible inhibitors of human kallikrein 7.
Arama DP; Soualmia F; Lisowski V; Longevial JF; Bosc E; Maillard LT; Martinez J; Masurier N; El Amri C
Eur J Med Chem; 2015 Mar; 93():202-13. PubMed ID: 25682203
[TBL] [Abstract][Full Text] [Related]
6. New imidazo[2,1-b]thiazole derivatives: synthesis, in vitro anticancer evaluation, and in silico studies.
Park JH; El-Gamal MI; Lee YS; Oh CH
Eur J Med Chem; 2011 Dec; 46(12):5769-77. PubMed ID: 22033063
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and antiproliferative activity of 3,4-diarylpyrazole-1-carboxamide derivatives against melanoma cell line.
El-Gamal MI; Choi HS; Cho HG; Hong JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Nov; 344(11):745-54. PubMed ID: 21954060
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 1H-pyrazole-1-carboxamide derivatives and their antiproliferative activity against melanoma cell line.
El-Gamal MI; Sim TB; Hong JH; Cho JH; Yoo KH; Oh CH
Arch Pharm (Weinheim); 2011 Mar; 344(3):197-204. PubMed ID: 21384419
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity of thieno[2,3-b]pyridine and furo[2,3-b]pyridine derivatives.
Hung JM; Arabshahi HJ; Leung E; Reynisson J; Barker D
Eur J Med Chem; 2014 Oct; 86():420-37. PubMed ID: 25194934
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of dehydroepiandrosterone-fused thiazole, imidazo[2,1-b]thiazole, pyridine steroidal analogues.
Zhang BL; Song LX; Li YF; Li YL; Guo YZ; Zhang E; Liu HM
Steroids; 2014 Feb; 80():92-101. PubMed ID: 24355392
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and structure--activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents.
Sajith AM; Abdul Khader KK; Joshi N; Reddy MN; Syed Ali Padusha M; Nagaswarupa HP; Nibin Joy M; Bodke YD; Karuvalam RP; Banerjee R; Muralidharan A; Rajendra P
Eur J Med Chem; 2015 Jan; 89():21-31. PubMed ID: 25462222
[TBL] [Abstract][Full Text] [Related]
12. Thee-component, one-pot synthesis of hexahydroazepino[3,4-b]indole and tetrahydro-1H-pyrido[3,4-b]indole derivatives and evaluation of their cytotoxicity.
Reddy BVS; Venkata Ganesh A; Vani M; Ramalinga Murthy T; Kalivendi SV; Yadav JS
Bioorg Med Chem Lett; 2014 Sep; 24(18):4501-4503. PubMed ID: 25176193
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines.
El-Gamal MI; Jung MH; Lee WS; Sim T; Yoo KH; Oh CH
Eur J Med Chem; 2011 Aug; 46(8):3218-26. PubMed ID: 21592628
[TBL] [Abstract][Full Text] [Related]
14. New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.
Deleuze-Masquefa C; Moarbess G; Khier S; David N; Gayraud-Paniagua S; Bressolle F; Pinguet F; Bonnet PA
Eur J Med Chem; 2009 Sep; 44(9):3406-11. PubMed ID: 19278757
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of new diarylamides with pyrimidinyl pyridine scaffold and evaluation of their anti-proliferative effect on cancer cell lines.
Abdelazem AZ; Al-Sanea MM; Park HM; Lee SH
Bioorg Med Chem Lett; 2016 Feb; 26(4):1301-4. PubMed ID: 26786696
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiproliferative activity of pyrrolo[3,2-b]pyridine derivatives against melanoma.
Kim HJ; Jung MH; Kim H; El-Gamal MI; Sim TB; Lee SH; Hong JH; Hah JM; Cho JH; Choi JH; Yoo KH; Oh CH
Bioorg Med Chem Lett; 2010 Jan; 20(1):413-7. PubMed ID: 19897366
[TBL] [Abstract][Full Text] [Related]
17. Novel 6-[(hetero)arylamino]thieno[3,2-b]pyridines: synthesis and antitumoral activities.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; São-José Nascimento M
Eur J Med Chem; 2010 Dec; 45(12):5732-8. PubMed ID: 20934235
[TBL] [Abstract][Full Text] [Related]
18. 5-Substituted [1]pyrindine derivatives with antiproliferative activity.
Kolb S; Goddard ML; Loukaci A; Mondésert O; Ducommun B; Braud E; Garbay C
Eur J Med Chem; 2010 Mar; 45(3):896-901. PubMed ID: 19969400
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines.
Willemann C; Grünert R; Bednarski PJ; Troschütz R
Bioorg Med Chem; 2009 Jul; 17(13):4406-19. PubMed ID: 19481463
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiproliferative activity evaluation of steroidal imidazo[1,2-a]pyridines.
Rassokhina IV; Volkova YA; Kozlov AS; Scherbakov AM; Andreeva OE; Shirinian VZ; Zavarzin IV
Steroids; 2016 Sep; 113():29-37. PubMed ID: 27263438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]